Immunosuppressive therapy with rituximab in common variable immunodeficiency

Common variable immunodeficiency (CVID) is the most frequent symptomatic primary antibody deficiency in adulthood and is characterized by the marked reduction of IgG and IgA serum levels. Thanks to the successful use of polyvalent immunoglobulin replacement therapy to treat and prevent recurrent inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Pecoraro, Antonio, Crescenzi, Ludovica, Galdiero, Maria Rosaria, Marone, Giancarlo, Rivellese, Felice, Rossi, Francesca Wanda, de Paulis, Amato, Genovese, Arturo, Spadaro, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501382/
https://www.ncbi.nlm.nih.gov/pubmed/31080365
http://dx.doi.org/10.1186/s12948-019-0113-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501382/
https://www.ncbi.nlm.nih.gov/pubmed/31080365
http://dx.doi.org/10.1186/s12948-019-0113-3

Ejemplares similares